Home | Welcome to Contract Pharma   
Last Updated Thursday, October 23 2014
Print

Breaking News

October 22, 2014
Janssen to produce more than one million doses of the investigational vaccine regimen in 2015  Read More »
October 22, 2014
Continued price and contracting pressures affect respiratory sales  Read More »
October 22, 2014
Revenues up 37% as TECFIDERA sales soar  Read More »
October 22, 2014
WuXi to perform FoundationOne assay at Shanghai Genome Center  Read More »
October 22, 2014
Supply of the new product will be available in early December   Read More »
October 22, 2014
Revenues up 14% in the quarter  Read More »
October 22, 2014
Lewis responsible for managing all quality-related functions  Read More »
October 21, 2014
Will begin large-scale manufacturing  Read More »
October 21, 2014
Expands drug development and bioavailability capabilities   Read More »
October 21, 2014
Will initially be operated in the packaging area for products for the Chinese market  Read More »
October 21, 2014
9,400-square foot unit is open and equipped for early-stage human studies  Read More »
October 21, 2014
Adds new immunotherapy platforms for cancer research   Read More »
October 21, 2014
To develop new indications for shelved compounds  Read More »
October 21, 2014
To add qualified equipment and capacity at its 30 locations  Read More »
October 20, 2014
“Direct to Patient” shipping adds flexibility for clinical trial participants  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On